Wockhardt Regenerative

Wockhardt Regenerative Private Limited is an Indian biotechnology and medical device company specializing in regenerative medicine and preventive healthcare. A subsidiary of the global pharmaceutical giant Wockhardt, the company focuses on developing advanced autologous growth factor concentrate (GFC) kits and exosome-based therapies. Its flagship products, including Ossinext for knee osteoarthritis and tendinopathies, and MYOWNN for facial rejuvenation and anti-aging, utilize a proprietary platelet activator to extract high concentrations of growth factors from a patient's own blood while eliminating pain-inducing red and white blood cells. These sterile, single-use medical devices are widely used by dermatologists, orthopedicians, and aesthetic professionals to promote natural tissue repair and regeneration.